Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.38 +7.6% TUNG 1.72 +1.8% LGO 1.01 −2.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.30 −2.0% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.73 −0.9% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.38 +7.6% TUNG 1.72 +1.8% LGO 1.01 −2.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.30 −2.0% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.73 −0.9%
Regulatory Admin

Cboe Canada Welcomes Listing of GuideAI Health Corp.

By The Northwire Desk — AI Analysis Jun 29, 2026 · 10:00 GDAI NaN
GDAI · Price

Executive Summary

  • Cboe Canada Inc. announced the listing of GuideAI Health Corp. ("GuideAI") on the Cboe Canada exchange.
  • GuideAI common shares began trading under the symbol GDAI.
  • GuideAI is an AI-driven healthcare company focused on early detection and management of vascular disease through its diagnostic platform.

Key Details

  • Listing Exchange: Cboe Canada Inc.
  • Company Listed: GuideAI Health Corp.
  • Trading Symbol: GDAI
  • Company Focus: Artificial intelligence healthcare technology for improving detection, management, and outcomes of vascular disease.
  • Technology: AI platform designed to transform complex medical imaging and clinical data into actionable diagnostic insights, specifically analyzing routine CT scans to identify peripheral vascular disease.
  • Target Market: Making advanced cardiovascular diagnostic intelligence accessible to healthcare providers beyond major academic and research centers.
  • Exchange Benefits: Access to an internationally recognized exchange with expertise in emerging sectors and capital formation for innovative companies.
  • Investor Access: Shares available through usual investment channels, including discount brokerages and full-service dealers.

Notable Quotes

  • Joacim Wiklander, CEO, Cboe Canada: "We are pleased to welcome GuideAI to Cboe Canada... Their work at the intersection of artificial intelligence and cardiovascular health represents exactly the kind of innovative, high-growth company that Canadian public markets should be supporting."
  • Raj Shah, CEO, GuideAI Health Corp.: "Going public marks an important milestone for GuideAI as we scale our platform and broaden access to life-changing diagnostic technology... We are excited to join the Cboe Canada community and look forward to delivering on our mission for patients, clinicians, and shareholders alike."
Read the original news release →

More from NaN

Jun 29, 2026 · 08:00

AI-driven vascular disease detection moves to public markets, but execution and commercialization remain unproven.

Regulatory